Fentiazac
CAS No. 18046-21-4
Fentiazac( —— )
Catalog No. M34251 CAS No. 18046-21-4
Fentiazac(BR-700) is an orally active nonsteroidal alkanoic acid derivative with significant analgesic, anti-inflammatory, and antipyretic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 61 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 55 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 50MG | 272 | In Stock |
|
| 100MG | 440 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFentiazac
-
NoteResearch use only, not for human use.
-
Brief DescriptionFentiazac(BR-700) is an orally active nonsteroidal alkanoic acid derivative with significant analgesic, anti-inflammatory, and antipyretic activity.
-
DescriptionFentiazac, alkanoic acid derivative, is an orally active non-steroidal anti-inflammatory agent, with analgesic, antipyretic and platelet anti-aggregation activity. Fentiazac can be used to research inflammatory diseases such as rheumatoid arthritis, osteoarthritis and tendinitis.
-
In Vitro——
-
In VivoFentiazac is well tolerated after repeated oral administration in rats, monkeys and dogs; and no significant modifications in the heart and bone marrow function, as well as blood chemistry.Tolerance of Fentiazac in rat, monkey and dog.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number18046-21-4
-
Formula Weight329.8
-
Molecular FormulaC17H12ClNO2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (303.21 mM; Ultrasonic )
-
SMILESC(C(O)=O)C1=C(N=C(S1)C2=CC=CC=C2)C3=CC=C(Cl)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Emilio Marmo, et al. Experimental and clinical pharmacology of fentiazac, a new, non-steroidal anti-inflammatory agent. Current Medical Research and Opinion.Volume 6, 1979 - Issue sup2.
molnova catalog
related products
-
Linzagolix
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.
-
CCP peptide TFA
CCP peptide TFA is a synthetic cyclocitrullinated peptide (CCP) that ACTS as a serum substrate for the detection of anti-ccp antibodies.
-
Isololiolide
Isololiolide has phytotoxicity, it inhibited seedling growth of cress and barnyard grass. It also showed in vitro activity against both trypomastigote and intracellular amastigotes of Trypanosoma cruzi, with IC50 values of 32 μM and 40 μM, respectively.
Cart
sales@molnova.com